Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sci-B-Vac vs Engerix-B in Dialysis Patients
NCT01933412Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Mar 2012
- Primary completion
- Aug 2013
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01933412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933412.